Ariel Dora Stern
Harvard University
H-index: 23
North America-United States
Top articles of Ariel Dora Stern
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation | Review of Economics and Statistics | Amitabh Chandra Jennifer Kao Kathleen L Miller Ariel D Stern | 2024/3/18 |
Differences in Care Team Response to Patient Portal Messages by Patient Race and Ethnicity | JAMA Network Open | Mitchell Tang Rebecca G Mishuris Lily Payvandi Ariel D Stern | 2024/3/4 |
Beyond the 510 (k): The regulation of novel moderate-risk medical devices, intellectual property considerations, and innovation incentives in the FDA’s De Novo pathway | npj Digital Medicine | Mateo Aboy Cristina Crespo Ariel Stern | 2024/2/8 |
Tracing Digital Therapeutics Research Across Medical Specialties: Evidence from ClinicalTrails. gov | Clinical Pharmacology & Therapeutics | Lars Masanneck Ariel D Stern | 2024/4/2 |
Evidence from ClinicalTrials. gov on the growth of digital health technologies in neurology trials | npj Digital Medicine | Lars Masanneck Pauline Gieseler William J Gordon Sven G Meuth Ariel D Stern | 2023/2/10 |
Effects of Remote Patient Monitoring Use on Care Outcomes Among Medicare Patients With Hypertension: An Observational Study | Annals of Internal Medicine | Mitchell Tang Carter H Nakamoto Ariel D Stern Jose R Zubizarreta Felippe O Marcondes | 2023/11 |
Association between regulatory submission characteristics and recalls of medical devices receiving 510 (k) clearance | JAMA | Alexander O Everhart Soumya Sen Ariel D Stern Yi Zhu Pinar Karaca-Mandic | 2023/1/10 |
Digital health reimbursement strategies of 8 European countries and Israel: scoping review and policy mapping | Robin van Kessel Divya Srivastava Ilias Kyriopoulos Giovanni Monti David Novillo-Ortiz | 2023/9/29 | |
Building the business case for an inclusive approach to digital health measurement with a web app (market opportunity calculator): instrument development study | JMIR Formative Research | Mitchell Tang Yashoda Sharma Jennifer C Goldsack Ariel Dora Stern | 2023/7/26 |
How Important is Editorial Gatekeeping? Evidence from Top Biomedical Journals | Review of Economics and Statistics | Joshua L Krieger Kyle R Myers Ariel D Stern | 2023 |
Dynamic HTA for digital health solutions: opportunities and challenges for patient-centered evaluation | Jan B Brönneke Annika Herr Simon Reif Ariel D Stern | 2023/11/17 | |
Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510 (k) Clearance—Reply | JAMA | Alexander O Everhart Yi Zhu Ariel D Stern | 2023/5/9 |
Federated electronic health records for the European Health Data Space | René Raab Arne Küderle Anastasiya Zakreuskaya Ariel D Stern Jochen Klucken | 2023/11/1 | |
AI insurance: how liability insurance can drive the responsible adoption of artificial intelligence in health care | NEJM Catalyst Innovations in Care Delivery | Ariel Dora Stern Avi Goldfarb Timo Minssen W Nicholson Price II | 2022/3/16 |
Ein Booster für die Pharmabranche | Harvard Business Manager | Christoph Grimpe Timo Minssen W Nicholson Price II Ariel D Stern | 2022/7 |
Advancing digital health applications: priorities for innovation in real-world evidence generation | Ariel D Stern Jan Brönneke Jörg F Debatin Julia Hagen Henrik Matthies | 2022/3/1 | |
Barriers to AI Adoption in Care Delivery | NEJM Catalyst Innovations in Care Delivery | Christina Silcox Ariel Dora Stern Thomas H Lee | 2022/5/6 |
The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives | Ariel Dora Stern | 2022/12/5 | |
Overcoming Legal Liability Obstacles to AI Adoption | NEJM Catalyst Innovations in Care Delivery | Ariel Dora Stern | 2022/5/5 |
Rapid Growth Of Remote Patient Monitoring Is Driven By A Small Number Of Primary Care Providers: Study examines the growth of remote patient monitoring. | Health Affairs | Mitchell Tang Ateev Mehrotra Ariel D Stern | 2022/9/1 |